Visby Medical’s STI Test for Women Gets FDA Clearance, CLIA Waiver
Visby Medical has received 510(k) clearance and was granted a CLIA waiver from the FDA for its second-generation POC sexual health test.
Read MorePosted by Andy Lundin | Mar 14, 2023 | Sexually Transmitted Diseases |
Visby Medical has received 510(k) clearance and was granted a CLIA waiver from the FDA for its second-generation POC sexual health test.
Read MorePosted by Andy Lundin | Mar 14, 2023 | Molecular Diagnostics |
Investigators developed a molecular test that identifies individuals most likely to benefit from hypnosis interventions to treat pain.
Read MorePosted by Andy Lundin | Mar 13, 2023 | Hematology & Serology, Tuberculosis |
A research team discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
Read MorePosted by Andy Lundin | Mar 10, 2023 | Covid 19 |
QuidelOrtho has been granted a De Novo request from the U.S. FDA, allowing the company to market its new Sofia 2 SARS Antigen+ FIA.
Read MorePosted by Andy Lundin | Mar 8, 2023 | Clinical Chemistry Analyzers, Urine Analyzers |
Shenzhen Superbio Technology received FDA clearance for its point-of-care instrument intended for the detection of fentanyl in human urine.
Read More